SCHEMBL6993267

SCHEMBL6993267

CC(Cl)Cn1cnc2sc3c(c2c1=O)CCN(C)C3

nearest known ligand 0.59

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 19/20 0.59
ADRA1D P25100 19/20 0.59
HTR1B P28222 19/20 0.59
ADRA1A P35348 19/20 0.59
ADRA1B P35368 19/20 0.59
SIGMAR1 Q99720 1/20 0.54
DRD2 P14416 1/20 0.53
HTR2A P28223 1/20 0.53
HTR2C P28335 1/20 0.53
HTR7 P34969 1/20 0.53
DRD3 P35462 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6993825 0.89 HTR1A (0.57) HTR1AADRA1DHTR1BADRA1AADRA1B
SCHEMBL3457276 0.85 HTR1A (0.64) HTR1AADRA1DHTR1BADRA1AADRA1B
SCHEMBL14142931 0.83 HTR1A (0.62) HTR1AADRA1DHTR1BADRA1AADRA1B
SCHEMBL3457233 0.83 NPC1 (0.67) HTR1AADRA1DHTR1BADRA1AADRA1B
SCHEMBL4499150 0.81 SIGMAR1 (0.53) HTR1AADRA1DHTR1BADRA1AADRA1B
SCHEMBL4493613 0.79 SIGMAR1 (0.53) HTR1AADRA1DHTR1BADRA1AADRA1B
SCHEMBL6990279 0.76 HTR1A (0.78) HTR1AADRA1DHTR1BADRA1AADRA1B
SCHEMBL6994673 0.76 HTR1A (0.74) HTR1AADRA1DHTR1BADRA1AADRA1B
Hydrochloric Acid SCHEMBL7715259 0.76 HTR1A (0.77) HTR1AADRA1DHTR1BADRA1AADRA1B
SCHEMBL6998104 0.75 HTR1A (0.74) HTR1AADRA1DHTR1BADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0927184-B1 3-SUBSTITUTED PYRIDO 4',3':4,5]THIENO 2,3-D]PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE ABBOTT GMBH & CO KG (DE) 2003-10-22 EP disclosed
US-6387912-B1 STROKE THERAPY BASF AKTIENGESELLSCHAFT (DE) 2002-05-14 US disclosed
US-6222034-B1 AS SEROTININ RECEPTOR ANTAGONISTS; FOR THERAPY OF DEPRESSION, CENTRAL NERVOUS SYSTEM DISORDERS BASF AKTIENGESELLSCHAFT (DE) 2001-04-24 US disclosed